Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AmplifiDx logo — The Might of Molecular

AmplifiDx

The Might of Molecular

Founded 2020 United States Newark, United States 12 employees Seed Total: $329.40K Biotechnology, Health Care +1

General Information

Company Name AmplifiDx
Founded Year 2020
Location United States Newark, United States
Employees 12
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with AmplifiDx. To contact AmplifiDx, visit amplifidx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About AmplifiDx

AmplifiDx, a **biotechnology and healthcare** startup based in the **United States**, has positioned itself as a significant player in the molecular point of care diagnostics industry since its establishment in **2020**. The company's slogan, "Next generation rapid molecular platform," captures its innovative approach to diagnostic solutions. In a major milestone, AmplifiDx secured a **Seed Round investment** on **January 1, 2022**, with participation from notable investors including **SeedFolio** and **Titan Angels**. This recent investment underscores the confidence that industry stakeholders have in the potential of AmplifiDx's offerings. As the startup continues to advance its cutting-edge molecular platform, it's poised to make a substantial impact within the healthcare sector.

Taxonomy: molecular diagnostics, point of care, rapid testing, AmplifiDx, diagnostic platform, molecular technology, innovation, next generation, biochemistry, biomedical engineering

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 2
SeedFolio Titan Angels
SeedFolio, Titan Angels
01 Jan 2022
Pre Seed Round $329.40K -
22 Jul 2021

AmplifiDx Alternatives & Competitors

View All Alternatives
AmplifiDx vs
FRIZ Biochem GmbH
FRIZ Biochem GmbH Germany

Taking Point-of-Care testing to the next level.

Grant
11 employees
Biotechnology, Health Care
AmplifiDx vs
Xagenic
Xagenic

Empowering clinicians with rapid, near-patient molecular testing for improved patient care and reduc...

Series B
Biotechnology, Health Care
AmplifiDx vs
Paratus Diagnostics
Paratus Diagnostics United States

Advancing Diagnostic Technology

Venture round
3 employees
Biotechnology, Health Care
View all alternatives

FAQ About AmplifiDx

The Might of Molecular
AmplifiDx was founded in 2020.
AmplifiDx is headquartered in Newark, United States.
AmplifiDx operates in Biotechnology, Health Care and Medical Devices. Its work centres on molecular diagnostics, point of care, rapid testing and AmplifiDx.
AmplifiDx has approximately 12 employees.
AmplifiDx has completed 2 funding rounds, raising a total of $329.40K. The latest funding stage is Seed.
Top alternatives and competitors to AmplifiDx include FRIZ Biochem GmbH, Xagenic, Paratus Diagnostics, Rivaara Labs, Rheonix, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AmplifiDx and FRIZ Biochem GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AmplifiDx, https://bouncewatch.com/company/amplifidx, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes